Purchase by RA CAPITAL MANAGEMENT, L.P. / RA Capital Healthcare Fund LP / Peter Kolchinsky / Rajeev M. Shah
9,906 shares · @ $24.46 · $242,323
Hemab Therapeutics Holdings, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $27.13
+13% in 3d after detection
Post-detection moves
1h
—
1d
+3.6%
3d
+13%
7d
+5.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS